Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Cancers|October 16, 2025
The Evolving Role of Hematopoietic Stem Cell Transplantation in Philadelphia-like Acute Lymphoblastic Leukemia: From High-Risk Standard to Precision StrategiesMatteo Molica, Claudia Simio, Laura De Fazio, et al.
Current Cancer Drug Targets|December 2, 2016
Chemotherapy and Cardiotoxicity in Hematologic MalignanciesAntonio Stellitano, Roberta Fedele, Santina Barilla, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast CancerPaolo Pedrazzoli, Massimo Martino, Sara Delfanti, et al.
Expert Opinion on Biological Therapy|December 15, 2015
Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agentsMassimo Martino, Moreno Festuccia, Roberta Fedele, et al.
Expert Review of Hematology|March 28, 2026
Reconsidering time from diagnosis to treatment in acute myeloid leukemia: from therapeutic urgency to biologically informed timingMatteo Molica, Laura De Fazio, Ferdinando Porretto, et al.
European Journal of Haematology|August 26, 2006
Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patientsMassimo Martino, Giulia Praticò, Giuseppe Messina, et al.
Expert Opinion on Biological Therapy|May 17, 2012
Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the artMassimo Martino, Roberta Fedele, Giuseppe Cornelio, et al.
Panminerva Medica|September 21, 2020
Chemotherapy-based regimens in multiple myeloma in 2020Massimo Gentile, Fortunato Morabito, Massimo Martino, et al.
European Journal of Haematology|October 18, 2006
Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patientsMassimo Martino, Giuseppe Console, Vincenzo Callea, et al.
Transplant Immunology|January 18, 2006
Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity settingSara Galimberti, Edoardo Benedetti, Fortunato Morabito, et al.
Pageof 17